Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$461M |
| 2 |
Qualcomm
QCOM
|
+$450M |
| 3 |
Marriott International
MAR
|
+$341M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$283M |
| 5 |
NRG Energy
NRG
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$962M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$551M |
| 3 |
WFM
Whole Foods Market Inc
WFM
|
+$510M |
| 4 |
Goldman Sachs
GS
|
+$478M |
| 5 |
Estee Lauder
EL
|
+$329M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.96% |
| 2 | Consumer Discretionary | 14.17% |
| 3 | Communication Services | 11.56% |
| 4 | Technology | 11.12% |
| 5 | Energy | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AZPN
701
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $378K | ﹤0.01% |
+8,151
| New | +$378K |
|
|
DRIV
702
DELISTED
DIGITAL RIVER INC.
DRIV
| $344K | ﹤0.01% |
22,262
-6,445
| -22% | -$103K |
|
|
PAY
703
DELISTED
Verifone Systems Inc
PAY
| $332K | ﹤0.01% |
+9,035
| New | +$308K |
|
704
Skyworks Solutions
SWKS
$8.98B
| $321K | ﹤0.01% |
+6,836
| New | +$288K |
|
705
Adtran
ADTN
$948M
| – | – |
-11,608
| Closed | -$283K |
|
706
AES
AES
$10.5B
| – | – |
-2,460,800
| Closed | -$35.1M |
|
707
AGCO
AGCO
$8.27B
| – | – |
-15,870
| Closed | -$875K |
|
708
Abercrombie & Fitch
ANF
$4.2B
| – | – |
-7,674
| Closed | -$295K |
|
709
A.O. Smith
AOS
$8.05B
| – | – |
-26,458
| Closed | -$609K |
|
710
AstraZeneca
AZN
$261B
| – | – |
-1,132,321
| Closed | -$73.5M |
|
711
Best Buy
BBY
$18B
| – | – |
-77,309
| Closed | -$2.04M |
|
712
Blackrock
BLK
$165B
| – | – |
-8,834
| Closed | -$2.78M |
|
713
PUT
Bristol-Myers Squibb
BMY
$124B
| – | – |
-242,000
| Closed | -$12.6M |
|
714
Conagra Brands
CAG
$6.73B
| – | – |
-903,651
| Closed | -$21.8M |
|
715
Cimpress
CMPR
$2.48B
| – | – |
-6,180
| Closed | -$304K |
|
716
Corcept Therapeutics
CORT
$9.8B
| – | – |
-2,151,617
| Closed | -$9.38M |
|
717
Carpenter Technology
CRS
$28.4B
| – | – |
-6,649
| Closed | -$439K |
|
718
CSX Corp
CSX
$94.4B
| – | – |
-252,084
| Closed | -$2.43M |
|
719
Cytokinetics
CYTK
$11B
| – | – |
-250,000
| Closed | -$2.38M |
|
|
720
PUT
Cytokinetics
CYTK
$11B
| – | – |
-250,000
| Closed | -$2.38M |
|
721
Donaldson
DCI
$10.5B
| – | – |
-7,100
| Closed | -$301K |
|
722
D.R. Horton
DHI
$42B
| – | – |
-17,910
| Closed | -$388K |
|
723
Danaher
DHR
$144B
| – | – |
-68,381
| Closed | -$3.45M |
|
724
Dick's Sporting Goods
DKS
$19.4B
| – | – |
-2,014,568
| Closed | -$110M |
|
|
725
Estee Lauder
EL
$29.9B
| – | – |
-4,923,791
| Closed | -$329M |
|
Similar funds
Jennison Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Jennison Associates held 796 positions worth $109B, up 4.1% from $105B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jennison Associates's Q2 2014 filing shows 64 new, 297 increased, 319 reduced and 90 closed positions. Its largest new stake was Qualcomm: 5,657,444 shares worth $448M. The largest sale was Allergan Inc, an estimated $962M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2014 buy was Qualcomm: 5,657,444 shares worth $448M.
- Jennison Associates added most to SLB Ltd in Q2 2014, an estimated $461M increase.
- Jennison Associates's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $962M.
- Jennison Associates fully exited Estee Lauder in Q2 2014, selling an estimated $329M.
- Jennison Associates's ten largest holdings make up 19% of its $109B portfolio in Q2 2014.
- Jennison Associates opened 64 new positions and closed 90 in Q2 2014.
- Jennison Associates's portfolio value rose 4.1% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2014, filed 8 Aug 2014.